Walker & Dunlop witnessed an incredible amount of demand for this financing given the best-in-class sponsor and attractive asset type, despite a challenging capital markets landscape during the COVID-19 pandemic,” - Keith Kurland. Despite the pandemic, Walker & Dunlop has arranged a $205 million refinancing loan for a Class A life sciences and medical office property.